Long term remissions with combined modality therapy for advanced Hodgkin's disease
โ Scribed by Leonard R. Prosnitz; Leonard R. Farber; James J. Fischer; Joseph R. Bertino; Diana B. Fischer
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- English
- Weight
- 554 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Optimal treatment for Hodgkin's disease during childhood is unknown. We report the treatment outcome of patients with Hodgkin's disease โค13 years of age seen at the American University of Beirut Medical Center (AUBMC) between 1980 and 1996. A retrospective review of the medical records of 24 childre
A patient with Hodgkin's disease (Stage IIB) was given nitrogen mustard shortly after diagnosis and has survived, without recurrence, for more than 5 years. HFhfOTHERAPY FOR CANCER IS OFTEN OF C palliative benefit but is only rarely curative. Single-agent chemotherapy4, 5 , 9 has achieved cure rate
Avascular necrosis of bone developed in eight patients with advanced Hodgkin's disease who had been treated with combined modality therapy and were in complete remission from their disease. A ninth patient not on protocol but treated with the combined modality program also developed avascular necros
Gonadal functions were evaluated in 92 male patients after treatment for advanced Hodgkin's disease. The patients received six to ten cycles of cyclophosphamide, vincristine, procarbazine, and prednisolone (COPP) chemotherapy. All patients were in remission and were followed for 1 to 17 years (media